Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ASBPW vs HYFM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ASBPW
Aspire Biopharma Holdings, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$125K
5Y Perf.-74.7%
HYFM
Hydrofarm Holdings Group, Inc.

Agricultural - Machinery

IndustrialsNASDAQ • US
Market Cap$5M
5Y Perf.-79.0%

ASBPW vs HYFM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ASBPW logoASBPW
HYFM logoHYFM
IndustryBiotechnologyAgricultural - Machinery
Market Cap$125K$5M
Revenue (TTM)$2K$146M
Net Income (TTM)$-32M$-65M
Gross Margin45.5%10.2%
Operating Margin-10314.0%-35.8%
Total Debt$1M$170M
Cash & Equiv.$4K$26M

ASBPW vs HYFMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ASBPW
HYFM
StockFeb 25May 26Return
Aspire Biopharma Ho… (ASBPW)10025.3-74.7%
Hydrofarm Holdings … (HYFM)10021.0-79.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: ASBPW vs HYFM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HYFM leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Aspire Biopharma Holdings, Inc. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
ASBPW
Aspire Biopharma Holdings, Inc.
The Long-Run Compounder

ASBPW is the clearest fit if your priority is long-term compounding.

  • -81.9% 10Y total return vs HYFM's -99.8%
  • -66.2% vs HYFM's -75.4%
Best for: long-term compounding
HYFM
Hydrofarm Holdings Group, Inc.
The Income Pick

HYFM carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.91
  • Rev growth -16.0%, EPS growth -1.9%, 3Y rev CAGR -26.5%
  • Lower volatility, beta 0.91, Low D/E 75.8%, current ratio 2.72x
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthHYFM logoHYFM-16.0% revenue growth vs ASBPW's -25.4%
Quality / MarginsHYFM logoHYFM-44.5% margin vs ASBPW's -16K%
Stability / SafetyHYFM logoHYFMBeta 0.91 vs ASBPW's 3.15
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)ASBPW logoASBPW-66.2% vs HYFM's -75.4%
Efficiency (ROA)HYFM logoHYFM-16.3% ROA vs ASBPW's -13.2%

ASBPW vs HYFM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ASBPWAspire Biopharma Holdings, Inc.

Segment breakdown not available.

HYFMHydrofarm Holdings Group, Inc.
FY 2024
Shipping and Handling
100.0%$8M

ASBPW vs HYFM — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHYFMLAGGINGASBPW

Income & Cash Flow (Last 12 Months)

HYFM leads this category, winning 3 of 5 comparable metrics.

HYFM is the larger business by revenue, generating $146M annually — 75447.2x ASBPW's $1,941. HYFM is the more profitable business, keeping -44.5% of every revenue dollar as net income compared to ASBPW's -16351.8%.

MetricASBPW logoASBPWAspire Biopharma …HYFM logoHYFMHydrofarm Holding…
RevenueTrailing 12 months$1,941$146M
EBITDAEarnings before interest/tax-$28M-$23M
Net IncomeAfter-tax profit-$32M-$65M
Free Cash FlowCash after capex-$4M-$8M
Gross MarginGross profit ÷ Revenue+45.5%+10.2%
Operating MarginEBIT ÷ Revenue-10314.0%-35.8%
Net MarginNet income ÷ Revenue-16351.8%-44.5%
FCF MarginFCF ÷ Revenue-1811.5%-5.7%
Rev. Growth (YoY)Latest quarter vs prior year-33.3%
EPS Growth (YoY)Latest quarter vs prior year+46.0%-22.7%
HYFM leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

HYFM leads this category, winning 1 of 1 comparable metric.
MetricASBPW logoASBPWAspire Biopharma …HYFM logoHYFMHydrofarm Holding…
Market CapShares × price$125,312$5M
Enterprise ValueMkt cap + debt − cash$1M$148M
Trailing P/EPrice ÷ TTM EPS-0.01x-0.07x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple
Price / SalesMarket cap ÷ Revenue0.03x
Price / BookPrice ÷ Book value/share0.02x
Price / FCFMarket cap ÷ FCF
HYFM leads this category, winning 1 of 1 comparable metric.

Profitability & Efficiency

Evenly matched — ASBPW and HYFM each lead in 2 of 4 comparable metrics.
MetricASBPW logoASBPWAspire Biopharma …HYFM logoHYFMHydrofarm Holding…
ROE (TTM)Return on equity-32.3%
ROA (TTM)Return on assets-13.2%-16.3%
ROICReturn on invested capital-9.6%
ROCEReturn on capital employed-12.1%
Piotroski ScoreFundamental quality 0–933
Debt / EquityFinancial leverage0.76x
Net DebtTotal debt minus cash$1M$143M
Cash & Equiv.Liquid assets$3,633$26M
Total DebtShort + long-term debt$1M$170M
Interest CoverageEBIT ÷ Interest expense-10.51x-3.77x
Evenly matched — ASBPW and HYFM each lead in 2 of 4 comparable metrics.

Total Returns (Dividends Reinvested)

ASBPW leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in ASBPW five years ago would be worth $1,810 today (with dividends reinvested), compared to $16 for HYFM. Over the past 12 months, ASBPW leads with a -66.2% total return vs HYFM's -75.4%. The 3-year compound annual growth rate (CAGR) favors ASBPW at -43.4% vs HYFM's -56.8% — a key indicator of consistent wealth creation.

MetricASBPW logoASBPWAspire Biopharma …HYFM logoHYFMHydrofarm Holding…
YTD ReturnYear-to-date-18.3%-35.0%
1-Year ReturnPast 12 months-66.2%-75.4%
3-Year ReturnCumulative with dividends-81.9%-91.9%
5-Year ReturnCumulative with dividends-81.9%-99.8%
10-Year ReturnCumulative with dividends-81.9%-99.8%
CAGR (3Y)Annualised 3-year return-43.4%-56.8%
ASBPW leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

HYFM leads this category, winning 2 of 2 comparable metrics.

HYFM is the less volatile stock with a 0.91 beta — it tends to amplify market swings less than ASBPW's 3.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HYFM currently trades 21.8% from its 52-week high vs ASBPW's 16.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricASBPW logoASBPWAspire Biopharma …HYFM logoHYFMHydrofarm Holding…
Beta (5Y)Sensitivity to S&P 5003.15x0.91x
52-Week HighHighest price in past year$0.09$4.78
52-Week LowLowest price in past year$0.01$0.81
% of 52W HighCurrent price vs 52-week peak+16.9%+21.8%
RSI (14)Momentum oscillator 0–10052.454.8
Avg Volume (50D)Average daily shares traded23K41K
HYFM leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricASBPW logoASBPWAspire Biopharma …HYFM logoHYFMHydrofarm Holding…
Analyst RatingConsensus buy/hold/sell
Price TargetConsensus 12-month target
# AnalystsCovering analysts
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

HYFM leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). ASBPW leads in 1 (Total Returns). 1 tied.

Best OverallHydrofarm Holdings Group, I… (HYFM)Leads 3 of 6 categories
Loading custom metrics...

ASBPW vs HYFM: Frequently Asked Questions

7 questions · data-driven answers · updated daily

01

Which is the better long-term investment — ASBPW or HYFM?

Over the past 5 years, Aspire Biopharma Holdings, Inc.

(ASBPW) delivered a total return of -81. 9%, compared to -99. 8% for Hydrofarm Holdings Group, Inc. (HYFM). Over 10 years, the gap is even starker: ASBPW returned -81. 9% versus HYFM's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

02

Which is safer — ASBPW or HYFM?

By beta (market sensitivity over 5 years), Hydrofarm Holdings Group, Inc.

(HYFM) is the lower-risk stock at 0. 91β versus Aspire Biopharma Holdings, Inc. 's 3. 15β — meaning ASBPW is approximately 244% more volatile than HYFM relative to the S&P 500.

03

Which is growing faster — ASBPW or HYFM?

On earnings-per-share growth, the picture is similar: Hydrofarm Holdings Group, Inc.

grew EPS -1. 9% year-over-year, compared to -381. 5% for Aspire Biopharma Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

04

Which has better profit margins — ASBPW or HYFM?

Hydrofarm Holdings Group, Inc.

(HYFM) is the more profitable company, earning -35. 1% net margin versus -16351. 8% for Aspire Biopharma Holdings, Inc. — meaning it keeps -35. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HYFM leads at -27. 4% versus -10314. 0% for ASBPW. At the gross margin level — before operating expenses — ASBPW leads at 45. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

05

Which pays a better dividend — ASBPW or HYFM?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

06

Is ASBPW or HYFM better for a retirement portfolio?

For long-horizon retirement investors, Hydrofarm Holdings Group, Inc.

(HYFM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 91)). Aspire Biopharma Holdings, Inc. (ASBPW) carries a higher beta of 3. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HYFM: -99. 8%, ASBPW: -81. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

07

What are the main differences between ASBPW and HYFM?

These companies operate in different sectors (ASBPW (Healthcare) and HYFM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ASBPW

Quality Business

  • Sector: Healthcare
  • Market Cap > $20B
  • Gross Margin > 27%
Run This Screen
Stocks Like

HYFM

Quality Business

  • Sector: Industrials
  • Market Cap > $100B
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.